Literature DB >> 22497282

Plasma lipid metabolites are associated with gestational age but not bronchopulmonary dysplasia.

Lynette K Rogers1, Christine M Young, Michael L Pennell, Trent E Tipple, Karen L Leonhart, Stephen E Welty.   

Abstract

AIM: To test the hypothesis that plasma lipid metabolite levels in premature infants are associated with the development of bronchopulmonary dysplasia (BPD). The studies also tested a secondary hypothesis that plasma lipid metabolite levels were correlated with gestational age.
METHODS: Infants born <32 weeks' gestation were enrolled during the first 72 h of life. Plasma samples were obtained and lipid levels were measured by LC-MS/MS. Clinical data were collected to determine infant outcomes and BPD diagnosis.
RESULTS: Following adjustment for confounders, lipid levels were not associated with BPD; however, levels of specific lipid metabolites were correlated with gestational age.
CONCLUSION: Immature lipid metabolism pathways in premature infants may contribute to the pathogenesis of BPD and other diseases.
© 2012 The Author(s)/Acta Paediatrica © 2012 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22497282      PMCID: PMC3693574          DOI: 10.1111/j.1651-2227.2012.02694.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  23 in total

1.  Is COPD in adulthood really so far removed from early development?

Authors:  W Shi; D Warburton
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

2.  Cysteinyl leukotriene involvement in chronic lung disease in premature infants.

Authors:  A J Cook; B Yuksel; A P Sampson; A Greenough; J F Price
Journal:  Eur Respir J       Date:  1996-09       Impact factor: 16.671

3.  Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study.

Authors:  Joseph Fawke; Sooky Lum; Jane Kirkby; Enid Hennessy; Neil Marlow; Victoria Rowell; Sue Thomas; Janet Stocks
Journal:  Am J Respir Crit Care Med       Date:  2010-04-08       Impact factor: 21.405

4.  Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.

Authors:  S Sheikh; D Null; D Gentile; C Bimle; D Skoner; K McCoy; R Guthrie
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

5.  Analysis of repeated pregnancy outcomes.

Authors:  Germaine Buck Louis; Vanja Dukic; Patrick J Heagerty; Thomas A Louis; Coutney D Lynch; Louise M Ryan; Enrique F Schisterman; Ann Trumble
Journal:  Stat Methods Med Res       Date:  2006-04       Impact factor: 3.021

6.  The role of chorioamnionitis and prostaglandins in preterm labor.

Authors:  C W van der Elst; A Lòpez Bernal; C C Sinclair-Smith
Journal:  Obstet Gynecol       Date:  1991-05       Impact factor: 7.661

7.  Role of EETs in regulation of endothelial permeability in rat lung.

Authors:  Diego F Alvarez; Eli-Anne B Gjerde; Mary I Townsley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-10-24       Impact factor: 5.464

Review 8.  The role of leukotrienes in inflammation.

Authors:  W R Henderson
Journal:  Ann Intern Med       Date:  1994-11-01       Impact factor: 25.391

Review 9.  Lung development and adult lung diseases.

Authors:  Wei Shi; Saverio Bellusci; David Warburton
Journal:  Chest       Date:  2007-08       Impact factor: 9.410

10.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia.

Authors:  Alecia Thompson; Vineet Bhandari
Journal:  Biomark Insights       Date:  2008-07-02
View more
  7 in total

1.  Attenuation of miR-17∼92 Cluster in Bronchopulmonary Dysplasia.

Authors:  Lynette K Rogers; Mary Robbins; Duaa Dakhlallah; Zhaogang Yang; L James Lee; Madison Mikhail; Gerard Nuovo; Gloria S Pryhuber; Gerald McGwin; Clay B Marsh; Trent E Tipple
Journal:  Ann Am Thorac Soc       Date:  2015-10

2.  miR-29b supplementation decreases expression of matrix proteins and improves alveolarization in mice exposed to maternal inflammation and neonatal hyperoxia.

Authors:  Shaheen Durrani-Kolarik; Caylie A Pool; Ashley Gray; Kathryn M Heyob; Mary J Cismowski; Gloria Pryhuber; L James Lee; Zhaogang Yang; Trent E Tipple; Lynette K Rogers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-04       Impact factor: 5.464

3.  Cyclooxygenase-2 in newborn hyperoxic lung injury.

Authors:  Rodney D Britt; Markus Velten; Trent E Tipple; Leif D Nelin; Lynette K Rogers
Journal:  Free Radic Biol Med       Date:  2013-04-25       Impact factor: 7.376

4.  DHA suppresses chronic apoptosis in the lung caused by perinatal inflammation.

Authors:  Mehboob Ali; Kathryn M Heyob; Markus Velten; Trent E Tipple; Lynette K Rogers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-02       Impact factor: 5.464

5.  Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension.

Authors:  Michael R La Frano; Johannes F Fahrmann; Dmitry Grapov; Theresa L Pedersen; John W Newman; Oliver Fiehn; Mark A Underwood; Karen Mestan; Robin H Steinhorn; Stephen Wedgwood
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-08-16       Impact factor: 5.464

6.  Of mice and men: correlations between microRNA-17∼92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia.

Authors:  Mary E Robbins; Duaa Dakhlallah; Clay B Marsh; Lynette K Rogers; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-30       Impact factor: 5.464

7.  Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants.

Authors:  Lynette K Rogers; Amanda E Graf; Anisha Bhatia; Karen L Leonhart; Reena Oza-Frank
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.